Evidence map›Paper›PMID 36803161›Full record

ArticleEnvironmental health : a global access science source2023

Response to Tsuda et al. "demonstrating the undermining of science and health policy after the Fukushima nuclear accident by applying the toolkit for detecting misused epidemiological methods".

Enora Cléro, Claire Demoury, Bernd Grosche, Liudmila Liutsko, Yvon Motreff, Takashi Ohba, Deborah Oughton, Philippe Pirard, Agnès Rogel, Thierry Schneider and 3 more

Abstract readLetterComment
In one paragraph

Article in Environmental health : a global access science source, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Enora CléroHealth and Environment Division, Institute for Radiological Protection and Nuclear Safety (IRSN), Fontenay-aux-Roses, France.
Claire DemouryRisk and Health Impact Assessment Unit, Sciensano, Brussels, Belgium.
Bernd GroscheRetired Federal Office for Radiation Protection (BfS), Munich, Germany.
Liudmila LiutskoInstitute for Global Health (ISGlobal), Barcelona, Spain.
Yvon MotreffSanté publique France, F-94415, Saint-Maurice, France.
Takashi OhbaFukushima Medical University, 1 Hikarigaoka, Fukushima, Fukushima, 9601295, Japan.
Deborah OughtonNorwegian University of Life Sciences (NMBU), Center for Environmental Radioactivity (CERAD), Aas, Norway.
Philippe PirardSanté publique France, F-94415, Saint-Maurice, France.
Agnès RogelSanté publique France, F-94415, Saint-Maurice, France.
Thierry SchneiderNuclear Protection Evaluation Centre (CEPN), Fontenay-aux-Roses, France.
An Van NieuwenhuyseCentre for Environment and Health, Department of Public Health and Primary Care, Leuven, Belgium.
Dominique LaurierHealth and Environment Division, Institute for Radiological Protection and Nuclear Safety (IRSN), Fontenay-aux-Roses, France.
Elisabeth CardisInstitute for Global Health (ISGlobal), Barcelona, Spain. elisabeth.cardis@isglobal.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe SHAMISEN (Nuclear Emergency Situations - Improvement of Medical And Health Surveillance) European project was conducted in 2015-2017 to review the lessons learned from the experience of past nuclear accidents and develop recommendations for preparedness and health surveillance of populations affected by a nuclear accident. Using a toolkit approach, Tsuda et al. recently published a critical review of the article by Cléro et al. derived from the SHAMISEN project on thyroid cancer screening after nuclear accident. MAIN BODY: We address the main points of criticism of our publication on the SHAMISEN European project.

conclusionWe disagree with some of the arguments and criticisms mentioned by Tsuda et al. We continue to support the conclusions and recommendations of the SHAMISEN consortium, including the recommendation not to launch a mass thyroid cancer screening after a nuclear accident, but rather to make it available (with appropriate information counselling) to those who request it.

Indexed as

Fukushima Nuclear AccidentThyroid NeoplasmsEpidemiologic MethodsHealth PolicyHumansReview Literature as TopicEpidemiological methodsNuclear accidentOverdiagnosisScreeningThyroid cancer

Identifiers

PMID36803161
PMCPMC9936769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.